• AXIS Clinicals successfully completes 14th US FDA audit (June 2016)
  • AXIS Clinicals successfully completes US FDA audit for ICP-OES services (March 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Contact Us

 

India
Mr. Abhijit Chaudhari
Director – Business Development
AXIS Clinicals Limited 
1-121/1, Survey No.66 (Part) & 67(Part), 
Miyapur, Serilingampally, Hyderabad 
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

United States
Mr. Sidharth Mishra
Director – Business Development (U.S)
Axis Clinicals Ltd.
1711 Highway 10 East, Dilworth,
Minnesota, U.S.A
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Mexico
Jose Eric Lopez Canseco
Manager – Business Development
Axis Clinicals Latina.
Ing. Basiliso Romo Anguiano, 
225 Col. Gpe. Insurgentes, Del. G.A. Madero; C.P. 07870,
México D.F., MÉXICO
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Business Enquiry Form

Fact sheet

  • Over 1,600 clinical studies completed since inception
  • Over 290 bioanalytical methods developed
  • Over 38 successful Regulatory audits
  • Global footprint of operations with sites in India, U.S, Mexico & Thailand.
  • Two clinical facilities in India
  • 60+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 200+ approvals, EMEA : 70+ approvals, Canada : 20+ approvals, Australia : 30+ approvals
  • 350+ staff working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved

Design By Graypixel